Logo image of CAND.BR

CANDELA INVEST (CAND.BR) Stock Fundamental Analysis

Europe - EBR:CAND - BE0974298300 - Common Stock

1 EUR
-1.36 (-57.63%)
Last: 11/14/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, CAND scores 1 out of 10 in our fundamental rating. CAND was compared to 117 industry peers in the Capital Markets industry. While CAND seems to be doing ok healthwise, there are quite some concerns on its profitability. CAND has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CAND had negative earnings in the past year.
In multiple years CAND reported negative net income over the last 5 years.
CAND had a negative operating cash flow in each of the past 5 years.
CAND.BR Yearly Net Income VS EBIT VS OCF VS FCFCAND.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2023 2024 0 500K -500K 1M -1M

1.2 Ratios

The Return On Assets of CAND (-8.85%) is worse than 71.79% of its industry peers.
CAND has a worse Return On Equity (-32.90%) than 71.79% of its industry peers.
Industry RankSector Rank
ROA -8.85%
ROE -32.9%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CAND.BR Yearly ROA, ROE, ROICCAND.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2023 2024 0 50 -50 -100

1.3 Margins

CAND does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CAND.BR Yearly Profit, Operating, Gross MarginsCAND.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for CAND remains at a similar level compared to 1 year ago.
CAND has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CAND has a worse debt to assets ratio.
CAND.BR Yearly Shares OutstandingCAND.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2023 2024 200K 400K 600K 800K 1M
CAND.BR Yearly Total Debt VS Total AssetsCAND.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of 1.26, we must say that CAND is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.26, CAND perfoms like the industry average, outperforming 58.12% of the companies in the same industry.
CAND has a Debt/Equity ratio of 2.17. This is a high value indicating a heavy dependency on external financing.
CAND has a worse Debt to Equity ratio (2.17) than 60.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.17
Debt/FCF N/A
Altman-Z 1.26
ROIC/WACCN/A
WACCN/A
CAND.BR Yearly LT Debt VS Equity VS FCFCAND.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2023 2024 0 2M 4M 6M

2.3 Liquidity

A Current Ratio of 5.31 indicates that CAND has no problem at all paying its short term obligations.
CAND has a better Current ratio (5.31) than 92.31% of its industry peers.
A Quick Ratio of 4.82 indicates that CAND has no problem at all paying its short term obligations.
CAND has a Quick ratio of 4.82. This is amongst the best in the industry. CAND outperforms 90.60% of its industry peers.
Industry RankSector Rank
Current Ratio 5.31
Quick Ratio 4.82
CAND.BR Yearly Current Assets VS Current LiabilitesCAND.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CAND have decreased strongly by -449.40% in the last year.
Looking at the last year, CAND shows a small growth in Revenue. The Revenue has grown by 1.99% in the last year.
The Revenue has been decreasing by -6.33% on average over the past years.
EPS 1Y (TTM)-449.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.42%
Revenue 1Y (TTM)1.99%
Revenue growth 3Y-4.31%
Revenue growth 5Y-6.33%
Sales Q2Q%22.2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CAND.BR Yearly Revenue VS EstimatesCAND.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CAND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CAND.BR Price Earnings VS Forward Price EarningsCAND.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAND.BR Per share dataCAND.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CAND does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANDELA INVEST

EBR:CAND (11/14/2025, 7:00:00 PM)

1

-1.36 (-57.63%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.08M
Revenue(TTM)7.99M
Net Income(TTM)-756.70K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.47
P/tB 0.47
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.4
BVpS2.14
TBVpS2.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.85%
ROE -32.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 2.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.31
Quick Ratio 4.82
Altman-Z 1.26
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-449.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.42%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.99%
Revenue growth 3Y-4.31%
Revenue growth 5Y-6.33%
Sales Q2Q%22.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-963.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CANDELA INVEST / CAND.BR FAQ

What is the ChartMill fundamental rating of CANDELA INVEST (CAND.BR) stock?

ChartMill assigns a fundamental rating of 1 / 10 to CAND.BR.


What is the valuation status of CANDELA INVEST (CAND.BR) stock?

ChartMill assigns a valuation rating of 0 / 10 to CANDELA INVEST (CAND.BR). This can be considered as Overvalued.


What is the profitability of CAND stock?

CANDELA INVEST (CAND.BR) has a profitability rating of 0 / 10.